Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.5B; returns 1 day -0.3%, 1 week +5.7%, 1 year +110.3%.

Cogent Biosciences Inc. is a clinical-stage biotechnology company dedicated to discovering, developing, and commercializing precision therapies for genetically defined diseases. The company's primary focus revolves around its lead drug candidate, bezuclastinib, a highly selective and potent KIT inhibitor.

Groups COGT belongs to

• Biotechnology
• Clinical Stage Biotech
• Clinical Stage
• Precision Medicine
• Healthcare
• Oncology
• Rare Diseases
• Hematology
• Life Sciences

COGT financial model: income statement, cash flow and balance sheet